Listed below are the successful projects awarded in our first round of pump priming.
Dr Joseph Campo
, Director of Operations
Antigen Discovery, Inc (ADI) (USA)
Protein antibody markers of pneumococcal carriage in support of protein and whole cell vaccine trial design using pan-proteomic antibody screening.
More information about the project
Dr Roma Chilengi
, Chief Scientific Officer
Centre for Infectious Disease Research in Zambia (Zambia)
Measurement of Shigella-specific antibodies in the first two years of life in Zambian children to refine correlates of protection and determine the optimal window for vaccination
More information about the project
Dr Sean Elias
, Post-Doctoral Scientist
University of Oxford (UK)
Measuring non-typhoidal Salmonella specific antibodies in oral fluid as a non-invasive alternative to serum
More information about the project
Professor Daniela Ferreira
Reader in Respiratory Infection Immunity and Vaccines
Liverpool School of Tropical Medicine (UK)
Identification of correlates of protection against pneumococcal colonization
More information about the project
Boris Gavrilov
Director
Biologics Development Facility Huvepharma EOOD (Bulgaria)
Supporting the development of a DIVA compatible glycoconjugate vaccine for brucellosis
More information about the project
Dr Sami Gottlieb
Medical Officer
World Health Organisation (Switzerland)
Gonococcal Vaccine Preferred Product Characteristics and Public Health Value Proposition: Initial Global Stakeholder Consultation
More information about the project
Dr Michael Jarvis
Associate Professor
The Vaccine Group (TVG) Ltd (UK)
Attenuated herpesvirus-based vaccines for low-cost antibiotic-independent control of bacterial disease in livestock - a proof of concept study
More information about the project
Professor Constantino Lopez-Macias
Principal Investigator
Mexican Social Security Institute (Mexico)
Improving the production of a multivalent experimental vaccine against the diseases induced by Salmonella enterica
More information about the project
Dr Pietro Mastroeni
Reader Infection and Immunity
University of Cambridge (UK)
Using General Modules for Membrane Antigens (GMMA) as multivalent Salmonella vaccines for Low-Middle Income Countries (LMIC) and travellers
More information about the project
Dr Esther Muthumbi
PhD student, Research Medical Officer
KEMRI-Wellcome (Kenya)
Using seroepidemiology of non-Typhoidal Salmonella (NTS) in Kenya to understand changes in risks of invasion and transmission and direct the clinical development programme for vaccines against NTS
More information about the project
Dr Christine Rollier
Research Scientist
University of Oxford (UK)
A novel bivalent vaccine to prevent both Salmonella Typhi and Paratyphi infections: preclinical proof of concept
More information about the project
Dr Michelo Simuyandi
Research Fellow
Centre for Infectious Disease Research in Zambia (Zambia)
Field evaluation and validation of a novel and rapid ETEC diagnostic assay in a resource limited setting
More information about the project